Clinical trial

Syntrillo Telehealth Stroke Risk Reduction Study

NCT07124728

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2025-07-30

PhaseNA

Study timeline

Study start (actual)2025-07-30Date precision: day

Registry last updated2026-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Hypertension (HTN)unresolved

Stroke Preventionunresolved

Cardiovascular Risk Factorunresolved

Interventions

Technology-enabled Telehealth Care PlanBEHAVIORAL

Blood Pressure Monitoring DeviceDEVICE

Tenovi Smart PillboxDEVICE

Wearable Activity Trackers (Fitbit or Apple Watch)DEVICE

Healthie EHROTHER

Secure Messaging Platforms (TigerConnect, Weave, AirCall)OTHER

Antihypertensive Medication ManagementDRUG

Statin Medication ManagementDRUG

Antiplatelet or Anticoagulant TherapyDRUG

Laboratory Blood Test CollectionPROCEDURE

Sponsors & collaborators

Syntrillo, Inclead sponsor

Mapped research locations

CharlottesvilleVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07124728 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.